News - Mergers & Acquisitions, Galapagos

Filter

Popular Filters

News briefs from Alimera on Iluvien and Xencor on Xtend; Galapagos milestone and acquisition

17-01-2013

US biopharma company Alimera Sciences (Nasdaq: ALIM) says that the Spanish Agency of Drugs and Medical…

Alimera SciencesBiotechnologyCangenixGalapagosIluvienJanssenJohnson & JohnsonMergers & AcquisitionsOphthalmicsPharmaceuticalRegulationResearchXencorXtend

Back to top